Lifevantage Dividend Insights: Essential Details Before the Ex-Dividend Deadline on May 30, 2025
Generated by AI AgentAinvest Dividend Digest
Monday, May 26, 2025 7:48 pm ET1min read
LFVN--
LifeVantage Corporation has announced a dividend of $0.045 per share, with the ex-dividend date set for May 30, 2025, and the dividend payable on Jun 13, 2025. This announcement follows a previous dividend of $0.04 per share on Mar 17, 2025. Notably, the latest dividend is lower than the average dividend of $0.063 per share over the past ten distributions. This cash dividend reflects the company's continuing commitment to return value to shareholders.
Recently, LifeVantageLFVN-- has garnered attention with significant developments impacting its market performance and operations. As of late, an increase in short interest has been reported, with a notable rise to 1,410,000 shares by Feb 15, marking a 137.5% increase from Jan 31. Meanwhile, LifeVantage's stock has been identified as undervalued, with a price of $12.66 compared to an estimated fair value of $13.93 based on Discounted Cash Flow modeling. Over the past week, analysts have pointed out that LifeVantage's stock performance has exceeded expectations, with a return of 72.01% over the past year, outperforming other consumer staple stocks significantly.
In summary, LifeVantage's recent activities and financial health highlight a robust position in the market amid strategic growth initiatives. As investors approach the ex-dividend date on May 30, 2025, it is crucial to act promptly to secure the dividend payout. This date marks the final opportunity to purchase shares and be eligible for the dividend, with any acquisitions post-ex-dividend date not qualifying for this particular payout.
Recently, LifeVantageLFVN-- has garnered attention with significant developments impacting its market performance and operations. As of late, an increase in short interest has been reported, with a notable rise to 1,410,000 shares by Feb 15, marking a 137.5% increase from Jan 31. Meanwhile, LifeVantage's stock has been identified as undervalued, with a price of $12.66 compared to an estimated fair value of $13.93 based on Discounted Cash Flow modeling. Over the past week, analysts have pointed out that LifeVantage's stock performance has exceeded expectations, with a return of 72.01% over the past year, outperforming other consumer staple stocks significantly.
In summary, LifeVantage's recent activities and financial health highlight a robust position in the market amid strategic growth initiatives. As investors approach the ex-dividend date on May 30, 2025, it is crucial to act promptly to secure the dividend payout. This date marks the final opportunity to purchase shares and be eligible for the dividend, with any acquisitions post-ex-dividend date not qualifying for this particular payout.

Sip from the stream of US stock dividends. Your income play.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet